The phannacokinetics and extravascular diffusion of teicoplanin in rabbits and comparative efficacy with vancomycin in an experimental endocarditis model
- 1 May 1988
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 21 (5) , 621-631
- https://doi.org/10.1093/jac/21.5.621
Abstract
The serum protein binding, extravascular diffusion and urinary excretion of teicoplanin were studied in rabbits. Extravascular diffusion was studied after a 20 min iv infusion, and after one or five im injections (7·5 mg/kg), and was compared with the results obtained after im administration of vancomycin (7·5 and 15 mg/kg). In an experimental model of Staphylococcus aureus endocarditis, the efficacy of both antibiotics was also investigated. We observed teicoplanin serum protein binding of 87±4%. The serum concentrations of teicoplanin showed a three-phase exponential decline: T1/2α 0·11 ±0·01 h; T1/2β, l·4±0·4 h; T1/2γ, 8·3±2·2 h. Teicoplanin appeared to be slightly secreted by renal tubules. The extravascular diffusion and the therapeutic efficacy of both drugs were studied with intervals between two injections based on the same multiple of β half-life. Teicoplanin, like vancomydn, appeared slowly in extravascular fluid and the diffusibility of both drugs was similar. Peak extravascular concentrations of teicoplanin after 5 im injections were greater when the compound was administered every 16 h, rather than every 24 h and, for this drug, iv administration induced higher peak extravascular concentrations (P > 0·01) than im injection. In the experimental model of S. aureus endocarditis, vancomycin 9 mg/kg/12 h and teicoplanin 4·5 mg/kg/16 h were similarly active and more effective than teicoplanin 4·5 mg/kg/24 h.Keywords
This publication has 12 references indexed in Scilit:
- The pharmacokinetics and tissue penetration of teicoplaninJournal of Antimicrobial Chemotherapy, 1986
- Enoxacin compared with vancomycin for the treatment of experimental methicillin-resistant Staphylococcus aureus endocarditisAntimicrobial Agents and Chemotherapy, 1986
- Kinetics and bactericidal effect of gentamicin and latamoxef (moxalactam) in experimental Escherichia coli endocarditisJournal of Antimicrobial Chemotherapy, 1986
- Comparison of penicillin and vancomycin, individually and in combination with gentamicin and amikacin, in the treatment of experimental endocarditis induced by nutritionally variant streptococciAntimicrobial Agents and Chemotherapy, 1985
- Efficacy of Vancomycin Plus Rifampin in Experimental Aortic-Valve Endocarditis Due to Methicillin-Resistant Staphylococcus aureus: In Vitro-in Vivo CorrelationsThe Journal of Infectious Diseases, 1985
- In vitro activity and human pharmacokinetics of teicoplaninAntimicrobial Agents and Chemotherapy, 1984
- Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1984
- VANCOMYCIN IN RABBITS - PHARMACOKINETICS, EXTRA-VASCULAR DIFFUSION, RENAL EXCRETION AND INTERACTIONS WITH FUROSEMIDE1982
- Single‐Dose Kinetics of Intravenous VancomycinThe Journal of Clinical Pharmacology, 1980
- Comparison of a radioimmunoassay and a microbiological assay for measurement of serum vancomycin concentrationsAntimicrobial Agents and Chemotherapy, 1980